Aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis: a trial sequential analysis

Int J Surg. 2024 Mar 1;110(3):1839-1840. doi: 10.1097/JS9.0000000000001003.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anticoagulants / adverse effects
  • Aspirin* / adverse effects
  • Heparin
  • Heparin, Low-Molecular-Weight* / adverse effects
  • Humans
  • Postoperative Complications
  • Venous Thromboembolism* / drug therapy
  • Venous Thromboembolism* / prevention & control

Substances

  • Anticoagulants
  • Aspirin
  • Heparin
  • Heparin, Low-Molecular-Weight